IPOGrid
0001817944
IPO filing research

Clarus Therapeutics Holdings, Inc.

Biological Products, (No Diagnostic Substances)

follow-on priced EFFECT

Clarus Therapeutics Holdings, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: EFFECT on 2023-03-06.

Filing Timeline

SEC EDGAR
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2023-03-06 · 9999999995-23-000526
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2023-03-06 · 9999999995-23-000525
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2023-03-06 · 9999999995-23-000524
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2023-03-06 · 9999999995-23-000522
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-08-26 · 0001193125-22-231364
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-08-26 · 0001193125-22-231349
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-08-26 · 0001193125-22-231342
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-08-26 · 0001193125-22-231336
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-08-19 · 0001193125-22-224588
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-08-19 · 0001193125-22-224585
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-08-19 · 0001193125-22-224582
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-08-19 · 0001193125-22-224578
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-08-10 · 0001193125-22-216490
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-08-10 · 0001193125-22-216486
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-08-10 · 0001193125-22-216485
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-08-10 · 0001193125-22-216482
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-06-15 · 0001193125-22-174836
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-06-15 · 0001193125-22-174824
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-06-15 · 0001193125-22-174817
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-06-15 · 0001193125-22-174808
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-06-09 · 0001193125-22-171072
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-06-09 · 0001193125-22-171061
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-06-09 · 0001193125-22-171044
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2022-06-09 · 0001193125-22-171039
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2022-06-01 · 9999999995-22-001664
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1 and confirms the priced prospectus.
2022-06-01 · 0001193125-22-165298
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
2022-05-24 · 0001193125-22-158662
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-05-17 · 0001193125-22-152097
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-05-17 · 0001193125-22-152090
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-05-17 · 0001193125-22-152082
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-05-03 · 0001193125-22-138816
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-05-03 · 0001193125-22-138808
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-05-03 · 0001193125-22-138796
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B4 and confirms the priced prospectus.
2022-05-03 · 0001193125-22-138781
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2022-04-27 · 0001193125-22-120838
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2022-04-25 · 9999999995-22-001080
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2022-04-25 · 0001193125-22-116282
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2022-04-21 · 0001193125-22-113174
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
2022-04-11 · 0001193125-22-101090
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2022-04-07 · 9999999995-22-000862
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2022-04-07 · 9999999995-22-000859
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-02-25 · 0001193125-22-054521
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-02-25 · 0001193125-22-054508
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-01-19 · 0001193125-22-011866
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2022-01-19 · 0001193125-22-011861
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2021-12-23 · 9999999995-21-004817
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2021-12-23 · 0001193125-21-366306
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1 and confirms the priced prospectus.
2021-12-22 · 0001193125-21-363815
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
2021-12-17 · 0001193125-21-361352
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2021-12-07 · 0001193125-21-350419
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows DRS and confirms the priced prospectus.
2021-11-19 · 0001193125-21-335285
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
Begins the tracked draft filing sequence after EFFECT.
2021-11-01 · 0000950123-21-013765
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2021-10-07 · 9999999995-21-003824
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1 and confirms the priced prospectus.
2021-10-07 · 0001213900-21-051870
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 425 in the pre-IPO sequence.
2021-09-30 · 0001213900-21-050782
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 424B3 in the pre-IPO sequence.
2021-08-11 · 0001213900-21-041722
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 425 and confirms the priced prospectus.
2021-08-11 · 0001213900-21-041720
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows EFFECT in the pre-IPO sequence.
2021-07-30 · 0001213900-21-039575
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2021-07-23 · 9999999995-21-002896
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-4/A and confirms the priced prospectus.
2021-07-23 · 0001213900-21-038392
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2021-07-19 · 0001213900-21-037329
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4/A in the pre-IPO sequence.
2021-07-15 · 0001213900-21-036976
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2021-06-25 · 0001213900-21-034252
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2021-06-09 · 0001213900-21-031516
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2021-05-26 · 0001213900-21-029190
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2021-05-25 · 0001213900-21-029006
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4 in the pre-IPO sequence.
2021-05-19 · 0001213900-21-027745
S-4 filed
S-4
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2021-05-14 · 0001213900-21-026258
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2021-05-03 · 0001213900-21-024229
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 424B4 in the pre-IPO sequence.
2021-04-27 · 0001213900-21-022978
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2020-12-16 · 0001213900-20-043061
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows CERT and marks the registration effective.
2020-12-15 · 9999999995-20-003527
CERT inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows 8-A12B in the pre-IPO sequence.
2020-12-14 · 0001354457-20-000786
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows S-1/A and registers the class of securities for exchange listing.
2020-12-11 · 0001213900-20-042323
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2020-11-30 · 0001213900-20-039804
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
2020-09-03 · 0001213900-20-025114
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
2020-07-22 · 0001213900-20-018216
Comparable Deals

20 comparable deals

Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 20 using nearest neighbors.
Showing top 8 by similarity.
+9.1%
Median day-1
60%
Above issue
+0.7%
Median week-1
-20.9%
Downside (p10)
Attovia Therapeutics, Inc. ATTO
2026-08-05 $269M Day 1: +28.8% Wk 1: +18.6%
same SICrecent IPO
Scribe Therapeutics, Inc. SCTX
2026-07-24 $129M Day 1: +44.3% Wk 1: +37.2%
same SICrecent IPO
Odyssey Therapeutics, Inc. ODTX
2026-05-08 $279M Day 1: -8.8% Wk 1: -3.8%
same SICrecent IPO
Hemab Therapeutics Holdings, Inc. COAG
2026-05-01 $302M Day 1: +88.9% Wk 1: +43.0%
same SICrecent IPO
BlossomHill Therapeutics, Inc. BLSM
2026-08-07 $150M Day 1: +0.0% Wk 1: +0.0%
same SIC grouprecent IPO
Latigo Biotherapeutics, Inc. LTGO
2026-08-07 $346M Day 1: +1.4% Wk 1: +1.4%
same SIC grouprecent IPO
Braveheart Bio, Inc. BRVE
2026-08-06 $383M Day 1: +65.6% Wk 1: +66.7%
same SIC grouprecent IPO
Apnimed, Inc. APMD
2026-07-31 $192M Day 1: +43.6% Wk 1: +74.3%
same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.